NEW YORK (GenomeWeb News) - BioNanomatrix and Princeton University will use a $200,000 grant from the National Cancer Institute to develop a nanofluidics technology for cell fractionation, the company said today.
 
Under the two-year Small Technology Transfer Research grant, BioNanomatrix and Princeton’s Institute for the Science and Technology of Materials will develop a front-end sample-sorting component for the company’s BioNanomatrix whole-genome analytic platform.  
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.